The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential advance. Unlike shots, this approach offers a less invasive way to administer GLP-1 drugs. These https://estelleihll442357.ampedpages.com/glp-1-patches-a-new-approach-to-glucose-management-67963745